| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $584.3M | $598.4M | $600.7M |
| YoY Revenue Growth % | -2.4% | -0.4% | — |
| Gross Profit | $452.8M | $432.6M | — |
| Gross Margin % | 77.5% | 72.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$93.8M | -$109.4M | -$87.3M |
| Operating Margin % | -16.1% | -18.3% | -14.5% |
| Net Income (GAAP) | $394.1M | -$100.3M | -$30.4M |
| EBITDA (Normalized) | -$93.3M | -$108.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$4.8M | -$48.0M | -$25.6M |
| Capital Expenditures (CapEx) | $576.0K | $1.3M | — |
| Free Cash Flow (FCF) | -$5.3M | -$49.3M | -$25.6M |
| FCF Margin % | -0.9% | -8.2% | -4.3% |
| Return on Invested Capital (ROIC %) | -6.4% | -11.3% | — |
| Cash & Short-Term Equivalents | $128.3M | $159.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.28B | $922.3M | — |